FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

5 letters match. Newest first.

  1. Lion Street Medical, d/b/a Pensar Medical LLC

    FDA warns Pensar Medical over unreported wound-therapy injuries and missing device reporting procedures.

    High risk
  2. ASP Global, LLC. dba Anatomy Supply Partners, LLC.

    FDA cites ASP Global for quality-system, reporting, and unapproved-change violations involving Safe-T-Fill blood collection devices.

    High risk
  3. Wissner-Bosserhoff GmbH

    FDA warns German nursing bed maker Wissner-Bosserhoff over quality system failures and an unreported SafeControl handset correction.

    High risk
  4. Agena Bioscience, Inc.

    Agena Bioscience marketed its iPLEX HS Colon Panel with the MassARRAY4 System for clinical diagnosis without FDA clearance or approval.

    High risk
  5. InfuTronix LLC

    InfuTronix infusion pumps: complaint and quality-fix failures, an unreported correction, and administration set changes not cleared by FDA.

    High risk